Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease

Blood

Volumn 114, Issue 3, 2009, Pages 744-746

  Kuzmina, Zoya ^a   Greinix, Hildegard T ^a   Knobler, Robert ^a   Worel, Nina ^a   Kouba, Michal ^a   Weigl, Roman ^a   Körmöczi, Ulrike ^a   Rottal, Arno ^a   Pohlreich, David ^a   Zielinski, Christoph ^a   Pickl, Winfried F ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CD19+CD21- B LYMPHOCYTE; CELLULAR DISTRIBUTION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LETTER; MALE; MEMORY CELL; PRIORITY JOURNAL; PUVA; TREATMENT RESPONSE; CYTOLOGY; GRAFT VERSUS HOST REACTION; LYMPHOCYTE COUNT; PREDICTION AND FORECASTING; TREATMENT OUTCOME;

CD19 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR;

ANTIGENS, CD19; B-LYMPHOCYTES; GRAFT VS HOST DISEASE; HUMANS; LYMPHOCYTE COUNT; PHOTOPHERESIS; PREDICTIVE VALUE OF TESTS; RECEPTORS, COMPLEMENT 3D; TREATMENT OUTCOME;

EID: 70149113059     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-221028     Document Type: Letter

References (10)

1. + B cells identify patients with active chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14:208-219.
2. Miklos DB, Kim HT, Miller KH, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2005;105:2973-2978.
3. Fujii H, Cuvelier G, She K, et al. Biomarkers in newly diagnosed pediatric extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood. 2008;111:3276-3285.
4. Sarantopoulos S, Stevenson KE, Kim HT, et al. Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. Blood. 2009;113: 3865-3874.
5. Greinix HT, Socie G, Bacigalupo A, et al. Assessing the potential role of photopheresis in hematopoietic stem cell transplant. Bone Marrow Transplant. 2006; 38:265-273. (Pubitemid 44203776)
6. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versushost disease. I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945-956. (Pubitemid 41754712)
7. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transplant. 2006;12:252-266. (Pubitemid 43273710)
8. Schultz KR, Miklos DB, Fowler D, et al. Toward biomarkers for chronic graft-versushost disease: National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker working group report. Biol Blood Marrow Transplant. 2006;12:126-137. (Pubitemid 43138008)
9. Keenan RA, De Riva A, Corleis B, et al. Censoring of autoreactive B cell development by the pre-B cell receptor. Science. 2008;321:696-699.
10. Sims GP, Ettinger R, Shirota Y, et al. Identification and characterization of circulating human transitional B cells. Blood. 2005;105:4390-4398. (Pubitemid 40720786)